FDA Ethics Act of 2022

Bill 117 HR 8828, also known as the FDA Ethics Act of 2022, is a piece of legislation introduced in the US Congress. The main purpose of this bill is to establish ethical guidelines and standards for employees of the Food and Drug Administration (FDA).

The bill outlines various provisions aimed at promoting transparency, accountability, and integrity within the FDA. It requires FDA employees to adhere to a code of ethics that prohibits conflicts of interest, bribery, and other unethical behavior. The bill also establishes a process for reporting and investigating ethical violations within the agency.

Additionally, the FDA Ethics Act of 2022 requires FDA employees to disclose any financial interests or relationships that may pose a conflict of interest. This is intended to prevent undue influence from outside parties and ensure that FDA decisions are based on scientific evidence and public health considerations. Overall, the FDA Ethics Act of 2022 seeks to strengthen the ethical standards and integrity of the FDA, ultimately enhancing public trust in the agency and its regulatory decisions.